The store will not work correctly when cookies are disabled.
4-(2,3-Dihydro-imidazo[2,1-a]isoquinolin-5-yl)-phenol
ID: ALA81715
PubChem CID: 135503537
Max Phase: Preclinical
Molecular Formula: C17H14N2O
Molecular Weight: 262.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1
Standard InChI: InChI=1S/C17H14N2O/c20-14-7-5-12(6-8-14)16-11-13-3-1-2-4-15(13)17-18-9-10-19(16)17/h1-8,11,20H,9-10H2
Standard InChI Key: SLBRKSWFKKEJBR-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
6.5792 -2.8125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0667 -3.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6167 -2.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1042 -1.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5542 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0667 -3.7167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -2.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2167 -2.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5125 -2.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5042 -1.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -3.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -3.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4042 -2.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1042 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1125 -2.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0042 -2.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0167 -3.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0542 -1.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5042 -2.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5250 -2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 8 1 0
11 1 1 0
12 11 1 0
13 14 1 0
14 10 2 0
15 9 1 0
16 13 1 0
17 5 1 0
18 7 1 0
19 17 2 0
20 18 2 0
12 6 1 0
7 5 2 0
13 15 2 0
19 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.31 | Molecular Weight (Monoisotopic): 262.1106 | AlogP: 2.97 | #Rotatable Bonds: 1 |
Polar Surface Area: 35.83 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.98 | CX Basic pKa: 7.19 | CX LogP: 2.65 | CX LogD: 2.54 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.86 | Np Likeness Score: 0.10 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |